Advertisement

Topics

Companies Related to "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" [Most Relevant Company Matches] - Page: 2 RSS

07:45 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" found in our extensive corporate database of over 50,000 company records.

Showing "Development Algorithm Prediction Onset Hemodynamic Instability Humans" Companies 26–50 of 6,000+

Relevant

Onset Medical Corporation


Senesco Technologies

We are engaged in the research and development of genetic technologies to improve commercial agriculture and to treat major medical conditions in humans. Our platform technology is based on the identification and characterization of specific genes that are responsible for plant cell death (senescence) and for programmed cell death in humans (apoptosis). We are developing our technologies to addre...

TolerRx, Inc.

We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immunological diseases. TolerRx has a development pipeline which includes two humanized antibodies that are in clinical trials for new-onset type 1 diabetes, psoriasis, and cutaneous lupus erythematosus. We also have ongoing research and development programs foc...


Pulse Metric, Inc

Physicist Shiu-Shin Chio, Ph.D., founded Pulse Metric in 1990 and serves as Chairman of the Board. His founding vision continues to guide the company today: To apply principles of biophysics and computer technologies to the development of advanced non-invasive tools that will help clinicians better detect and treat hypertension, heart failure and associated cardiovascular disease.Pulse Metric, Inc...

Cardiodynamics International

CardioDynamics (NASDAQ: CDIC) is committed to fundamentally changing drug management with ICG. The Company's primary product, the BioZ®, uses proprietary Impedance Cardiography (ICG) technology to noninvasively assess a patient's hemodynamics, data which typically has been available only through a time-consuming, costly, and potentially dangerous invasive procedure called Pulmonary Artery Cathete...

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products target market opportunities through formulation based product improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of pain products that incorporate ...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market potential, improve the quality of care, or have unmet needs. Fero’s initial focus is on diabetes. The Company has acquired the intellectual property and other exclusive world-wide rights related to...

Zen-Bio, Inc

Zen-Bio was created to meet the urgent need of investigators interested in understanding human obesity, diabetes, and cardiovascular disease. While rodent models are useful for deciphering metabolic pathways of energy partitioning, the critical analyses for drug development in humans requires an appropriate in vitro model to study human adipocytes.

Probably Relevant

Divergence Inc.,

Divergence Inc., a world leader in the application of genomics to agriculture and infectious disease, discovers and develops proprietary products for the safe and effective control of parasitic diseases. Plant parasitic nematodes are the largest unsolved pest problem in agricultural chemistry. Despite billions of dollars in annual crop damage, current means of control are limited and environmental...

Carmenta Bioscience, Inc.

Carmenta Bioscience is a privately held, medical technology company focused on advancing maternal and fetal health by applying a systems biology approach to the diagnosis and prediction of preeclampsia. Carmenta’s products in development combine proprietary computational algorithms with novel serum protein measurements to classify pregnant mothers at ...

NexBio Incorporated

In recent years the world has witnessed the outbreak of SARS, the worldwide spread of avian influenza viruses, and the escalating outbreaks of avian influenza viruses in humans. The present unavailability of a vaccine against avian influenza infection in humans is of grave concern. Health authorities worldwide fear an imminent and inevitable influenza pandemic in addition to the more routine but ...

GangaGen, Inc.

GangaGen, Inc. is a biotechnology company focused on the development of proprietary, bacteriophage-based products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. The Company's bacteriophage, both natural and engineered, can be applied broadly to kill bacteri...

Auxogyn, Inc.

Auxogyn – Advancing women’s reproductive health through novel scientific and clinical knowledge of early human developmental biology auxology (from Greek αὔξω, auxō, or αὐξάνω, auxanō, "growth") is a meta-term covering the study of human growth and biology gynaecology or gynecology (from Greek gynaikos meaning woman) is the medical...

Sensifree

Sensifree is a clinical-stage medical device company developing products based on its proprietary NEST (Noninvasive Electromagnetic Sensing Technology) platform for continuous and noninvasive hemodynamic monitoring. The Company’s first product, a blood pressure monitor, will be a valuable tool at the hands of anesthesiologists, enabling them to increa...

MathWorks, Inc.

MathWorks is the leading developer of mathematical computing software. MATLAB, the language of technical computing, is a programming environment for algorithm development, data analysis, visualization, and numeric computation. Simulink is a graphical environment for simulation and Model-Based Design of multidomain dynamic and embedded systems. Engineers an...

Molsoft L.L.C.

Welcome to Molsoft LLC! Molsoft a leading provider of tools, databases and consulting services in the area of structure prediction, structural proteomics, bioinformatics, cheminformatics, molecular visualization and animation, and rational drug design. Molsoft offers complete solutions customized for a biotechnology or pharmaceutical company in the areas of computational biology and chemistry. Mol...

Medality Medical LLC

Medality Medical LLC, a privately funded (including an NIH grant) medical technology company, is focused on reversing type 2 diabetes and associated obesity. Its patented proprietary technology enables the gentle and selective extraction of excess mesenteric visceral fat, which has been associated with insulin resistance, a precursor to type 2 diabetes. In...

VistaGen Therapeutics, Inc.

VistaGen Therapeutics is a biotechnology company focused on using proprietary pluripotent stem cell technology to discover, rescue and develop novel drug candidates for a broad range of diseases and conditions. VistaGen’s integrated stem cell technology platform, Human Clinical Trials in a Test Tube™, is based on the differentiation of human plur...

KineMed

KineMed was founded in 1999 to provide kinetic solutions to fundamental problems in disease management and drug development. Although it is widely recognized that all biological systems are characterized by flux (polymers are synthesized and degraded; metabolite traverse pathways to provide energy; cells die and are replaced), virtually no tests in biomedicine in the year 2004 measure dynamic flux...

Corthera Inc.

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-preg...

Ellipse Technologies, Inc.

Ellipse Technologies, Inc. is dedicated to the design, development and successful commercialization of noninvasively adjustable implants for orthopedic deformity and trauma procedures. The Ellipse technology is protected by a number of issued patents and numerous pending patents. Its initial commercial product, the MAGEC™ System, restores proper anato...

Teva Pharmaceuticals USA, Inc.

Alexza Pharmaceuticals is focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions, including agitation, acute repetitive seizures and insomnia. Alexza's products are based on the Staccato® system, a hand-held inhaler that is designed to deliver a drug aerosol ...

HemoShear, LLC

HemoShear LLC is a biotechnology research company that combines its scientific expertise with its proprietary platform technology in research collaborations with pharmaceutical companies to accelerate drug discovery and development. HemoShear has expertise in the areas of human and animal biology, bioinformatics and molecular profiling for target identific...

Xceleron

Founded in 1997 in York, UK, Xceleron provides unique and robust human data and insights to inform the full range of decisions that determine drug development success, from early preclinical testing through late-stage development. Xceleron leverages its expertise in microtracing, microdosing, and AMS to provide unprecedented insights into how drug candidat...

NeuroVia, Inc.

NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits associated with X-ALD.


More From BioPortfolio on "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks